The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of ribociclib and everolimus in p16 low anaplastic thyroid cancer (ATC).
 
Bernard Tawfik
No Relationships to Disclose
 
David E. Gerber
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Bristol-Myers Squibb; Samsung Bioepis
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - ArQule (Inst); BerGenBio (Inst); ImClone Systems (Inst); Immunogen (Inst); Karyopharm Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Decision Support in Medicine from the Clinical Decision Support--Oncology on-line program.; Royalties from Oxford University Press from two books.
Travel, Accommodations, Expenses - ArQule; Bristol-Myers Squibb; Lilly; Lilly
 
Barbara Burtness
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Debiopharm Group; MedImmune; Merck; VentiRx
Research Funding - Merck
 
Randall S. Hughes
No Relationships to Disclose
 
Larry L. Myers
No Relationships to Disclose
 
Baran D. Sumer
No Relationships to Disclose
 
John Truelson
Stock and Other Ownership Interests - Merck (I); Pfizer (I)
 
Tobin Joel Strom
No Relationships to Disclose
 
Pamela Kurian
No Relationships to Disclose
 
Sehresh Saleem
No Relationships to Disclose
 
Jean Pearson
No Relationships to Disclose
 
Hong Zhu
No Relationships to Disclose
 
Saad A. Khan
Honoraria - ARIAD; EMD Serono; Genentech/Roche; Genzyme
Consulting or Advisory Role - ARIAD; EMD Serono; Genentech/Roche
Speakers' Bureau - Genzyme
Research Funding - Abbvie (Inst); Bayer/Onyx (Inst); Celldex (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Threshold Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Novartis